ASX - Delayed Quote • AUD Nova Eye Medical Limited (EYE.AX) Follow Compare 0.1450 -0.0200 (-12.12%) As of 2:36:43 PM GMT+11. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations We Think Nova Eye Medical (ASX:EYE) Can Afford To Drive Business Growth We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made... When Will Nova Eye Medical Limited (ASX:EYE) Turn A Profit? With the business potentially at an important milestone, we thought we'd take a closer look at Nova Eye Medical... Nova Eye Medical Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags Nova Eye Medical ( ASX:EYE ) Full Year 2024 Results Key Financial Results Revenue: AU$24.0m (up 41% from FY 2023). Net... Is There An Opportunity With Nova Eye Medical Limited's (ASX:EYE) 37% Undervaluation? Key Insights The projected fair value for Nova Eye Medical is AU$0.40 based on 2 Stage Free Cash Flow to Equity Current... Here's Why We're Not Too Worried About Nova Eye Medical's (ASX:EYE) Cash Burn Situation Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and... Performance Overview Trailing total returns as of 1/31/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] Return EYE.AX S&P/ASX 200 [XJO] YTD -9.38% +4.43% 1-Year -45.28% +10.93% 3-Year -51.67% +22.22%